Opracowana na Flinders University w Australii szczepionka prawdopodobnie nie tylko chroni przed chorobą, ale także przed przenoszeniem SARS-CoV-2.

The vaccine was developed at Flinders University in Australia, and is likely to not only protect against disease, but also against transmission of SARS-CoV-2.

According to researchers from Flinders University, the vaccine they developed against SARS-CoV-2 may not only protect against disease, but also protect against the spread of the virus.

The preparation contains a synthetically synthesized viral spike protein, developed with the help of artificial intelligence. The vaccine also includes Advax – an adjuvant based on a plant sugar – inulin.

The key to epidemic management is the development of an effective SARS-CoV-2 vaccine that will not only prevent infection and clinical disease, but also prevent transmission of the virus. – Nikolai Petrovsky, research team leader and research director at Vaxine Pty Ltd.

With different countries entering the second, third and even the next wave, the world urgently needs more effective vaccines, especially those that provide strong protection against all new variants of the virus and that are likely to prevent the transmission of the virus. – says the specialist.

A nurse can “vaccinate” more than 8 thousand with saline. Persons

Data collected in studies in mice and rodents indicate that the preparation is safe and effective, while at the same time giving hope that it may reduce the risk of disease transmission.

The animals did not release virus particles from their noses or transmit them to other individuals.

We have now collected data on nasal virus secretion and started testing on hamsters in the United States to see exactly whether the vaccine limits transmission of the disease to virus-free animals. Protecting against its transmission will change the situation, and this is what we need to prevent further outbreaks – Inform the professor. Petrovsky.

The vaccine must be stable under conditions achievable in standard refrigerators.

Its phase 2 clinical trial has also ended and the results will be published soon.

Third dose of vaccination in Israel: Antibody levels increased significantly

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Biblical Teachings and Family Studies. There is a list of MEiN

I have signed a list in which we establish new fields and…

Study: Confirmed how COVID-10 vaccine affects fertility

Experts have long argued that COVID-19 vaccines do not affect female and…

Large Magellanic Cloud. A disk around a star in another galaxy has been discovered for the first time

Astronomers have discovered a disk in the Large Magellanic Cloud around a…

Less than 6000 new cases of corona virus

Here are the numbers for Monday, March 7. In Wilkopolska, 654 new…